Medical Program: Breaking Down the KEYNOTE-189 Protocol for NSCLC

Breaking Down the KEYNOTE-189 Protocol for NSCLC

Breaking Down the KEYNOTE-189 Protocol for NSCLC
RestartResume

Get an in-depth look into KEYNOTE-189, a practice-changing clinical trial in the non-small cell lung cancer field.

  • Overview

    Tune in as Dr. Michael Shafique from the Moffitt Cancer Center explains the KEYNOTE-189 clinical trial, which investigated whether the addition of pembrolizumab to standard of care platinum-based chemotherapy would provide some survival benefit to patients with non-small cell lung cancer.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free